https://www.selleckchem.com/products/dyngo-4a.html
Children and young adults undergoing hematopoietic stem cell transplantation (HSCT) typically lose their immunity to vaccine-preventable diseases, including Japanese encephalitis (JE). Revaccination against JE in this population has not been well characterized. This prospective study evaluated the immunogenicity of inactivated Vero cell culture-derived JE vaccine in children and young adults (25 years of age) who had completed HSCT 1 year prior. Each patient received inactivated Vero cell culture-derived JE vaccine at enrollmen
Like
Comment
Share
